Best Podium and Poster Presentations Awarded at ISPOR 22nd Annual International Meeting

Published May 24, 2017
Boston, MA—May 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognized the Best Podium and Poster Presentation Awardees at its 22nd Annual International Meeting today in Boston, MA, USA. The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations at ISPOR’s Annual International Meetings, Annual European Congresses, Asia-Pacific Conferences, and Latin America Conferences. BEST PODIUM PRESENTATION AWARDS Best General Podium Presentation Awards
  • Stephen S Johnston, Johnson & Johnson Co., New Brunswick, NJ, USA MD4: COMPARISON OF ECONOMIC AND CLINICAL OUTCOMES BETWEEN THE DERMABOND® PRINEO® SKIN CLOSURE SYSTEM AND SKIN STAPLES IN PATIENTS UNDERGOING KNEE REPLACEMENT IN REAL WORLD CLINICAL PRACTICE
  • Kristina Secnik Boye, PhD, RPh, BS, MS, MPH, Eli Lilly and Company, Indianapolis, IN, USA PP4: VALIDATION OF A QUESTIONNAIRE TO ASSESS PATIENT PERCEPTIONS OF INJECTION DEVICES FOR TYPE 2 DIABETES
  • Frank Xiaoqing Liu, Merck and Co., Inc., North Wales, PA, USA PP1: COMPARISON OF PATIENT, ONCOLOGIST, AND ONCOLOGY NURSE PREFERENCES FOR ATTRIBUTES OF DRUG THERAPY IN ADVANCED MELANOMA
Best Student Podium Presentation Awards
  • Rahul Garg, West Virginia University, Morgantown, WV, USA CN2: IMPACT OF DIFFUSE LARGE B-CELL LYMPHOMA ON VISITS TO DIFFERENT PROVIDER SPECIALTIES AMONG ELDERLY MEDICARE BENEFICIARIES: CHALLENGES FOR CARE COORDINATION
  • Weihsuan Lo-Ciganic, PhD, MS, MSPharm, University of Arizona, Tucson, AZ, USA TP4: GEOGRAPHIC VARIATION OF INAPPROPRIATE PRESCRIPTION OPIOID USE AMONG DISABLED MEDICARE BENEFICIARIES
  • Yingnan Zhao, PhD, Xavier University of Louisiana, New Orleans, LA, USA DB2: RACIAL DISPARITY IN ACCESS TO NEWER CLASS ANTI-DIABETICS AMONG ADULT PATIENTS WITH DIABETES IN THE U.S.
Best New Investigator Podium Research Presentations
  • Lindsey A. Falk, Health Quality Ontario, Toronto, ON, USA MD1: COST EFFECTIVENESS OF THE LEFT ATRIAL APPENDAGE CLOSURE DEVICE COMPARED WITH ORAL ANTICOAGULANTS IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
  • Janki S. Bhatt, PhD, Cigna Health and Life Insurance Company, Bloomfield, CT, USA AD3: IMPACT OF MEDICATION ADHERENCE ON TOTAL MEDICAL COSTS
  • Chia-Te Liao, Chimei Medical Center, Tainan, Taiwan CV2: ECONOMIC EVALUATION OF ALTERNATIVE ANTICOAGULANT DRUGS FOR THE PREVENTION OF STROKE AMONG 65-YEAR OLD ATRIAL FIBRILLATION PATIENTS IN TAIWAN
BEST POSTER PRESENTATION AWARDS Best General Poster Research Presentations
  • Donatus (Don) Ekwueme, US CDC, Atlanta, GA, USA PIH22: ESTIMATION OF BREAST CANCER INCIDENT CASES AND MEDICAL CARE COSTS ATTRIBUTABLE TO ALCOHOL CONSUMPTION AMONG INSURED WOMEN UNDER AGE 45 YEARS IN THE UNITED STATES
  • Lori McLeod, RTI Health Solutions, Research Triangle Park, NC, USA PDB68: PSYCHOMETRIC EVALUATION OF THE NV QUESTIONNAIRE IN PATIENTS WITH T2DM RECEIVING A GLP-1 AGONIST
  • Yu Shen, UT MD Anderson Cancer Center, Houston, TX, USA PCN254: DO ADVANCES IN BREAST CANCER TREATMENT RENDER SCREENING MAMMOGRAPHY NOT COST-EFFECTIVE FOR AVERAGE-RISK WOMEN?
Best Student Poster Research Presentations
  • Arun Kumar, St. John’s University, New York, NY, USA PCV16: FONDAPARINUX SODIUM COMPARED WITH LOW MOLECULAR WEIGHT HEPARINS FOR THROMBOPROPHYLAXIS AMONG PATIENTS AT RISK AS PER VIRCHOW’S TRIAD: A SYSTEMATIC REVIEW AND META ANALYSIS
  • Pratik Rane, University of Houston, TX, USA PGI1: RISK OF CLOSTRIDIUM DIFFICILE INFECTION ASSOCIATED WITH PROTON PUMP INHIBITOR USE AMONG COMMUNITY DWELLING ADULTS WITH GASTROESOPHAGEAL REFLUX DISEASE
  • Nibu Parameswaran Nair, University of Tasmania, Hobart, Australia PIH4: REPEAT ADVERSE DRUG REACTION-RELATED HOSPITAL ADMISSIONS IN ELDERLY AUSTRALIANS
Best New Investigator Poster Research Presentations
  • Mayank R. Ajmera, RTI Health Solutions, Research Triangle Park, NC, USA PND25: INCREMENTAL ECONOMIC BURDEN OF CARDIOMETABOLIC DISORDERS AMONG PATIENTS WITH EPILEPSY
  • Tim Wiltshire, University of North Carolina, Chapel Hill, NC, USA PCV95: PROJECTED IMPACT OF ADOPTING A MULTIPLEXED PREEMPTIVE GENOTYPING INTERVENTION IN CARDIAC CATHETERIZATION LABORATORY PATIENTS
  • Sandipan Bhattacharjee, University of Arizona, Tucson, AZ, USA PCN79: HEALTHCARE EXPENDITURES AMONG COMMUNITY-DWELLING ADULTS WITH THYROID CANCER IN THE UNITED STATES: A PROPENSITY SCORE MATCHED ANALYSIS
Additional information on the ISPOR 22nd Annual International Meeting can be found here. Released presentations from the conference can be found here. Interested parties can follow news at ISPOR’s press site and on social media using the conference hashtag #ISPORBoston.

###

  ABOUT ISPOR The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB    

Related Stories

ISPOR Launches New Content on Whole Health

Sep 23, 2025

ISPOR announced that it has launched new website content on whole health, a topic of increasing importance as health systems across the globe grapple with providing the best possible healthcare to patients within constrained budgets.

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.

ISPOR Real-World Evidence Summit 28-30 September 2025 | Tokyo, Japan

Sep 9, 2025

ISPOR announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×